SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celera Genomics (CRA) -- Ignore unavailable to you. Want to Upgrade?

To: gao seng who wrote (480)6/26/2000 2:42:00 PM
From: bob zagorin  Read Replies (2) | Respond to of 746
 
I doubled my CRA today at 110. i'm convinced that CRA has a working business model. I like the partnership with GERN. I'm impressed with the IMNX deal. And I think they will blow people away with the speed at which they sequence proteins and other more commercial inf. once they turn those big PE analyzers toward those tasks.



To: gao seng who wrote (480)6/27/2000 2:55:00 AM
From: Walkingshadow  Read Replies (1) | Respond to of 746
 
gao seng,

Very interesting development. I'd say IMNX just upped the ante for AMGN, BGEN, DNA, etc.

So what's it gonna be, guys? Ya gonna see it, or ya gonna fold?

WS



To: gao seng who wrote (480)6/27/2000 3:09:00 PM
From: Ryan Mak  Read Replies (2) | Respond to of 746
 
Anyone listening to the conference today?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News